J., Klip, A., Nagy, A., Kim, J
Ideal candidates typically: Have struggled with weight control despite lifestyle modification Display signs of insulin resistance or metabolic syndrome Require medical assistance to prevent progression of obesity-related diseases Exclusion criteria may include individuals with a history of certain endocrine disorders, pancreatitis, or specific gastrointestinal diseases
Supports over 300 enzymatic reactions including energy production
In light of these data, we suggest therapies that target energy metabolism and ROS generation to improve kidney function recovery may need to also target the energy and redox derangements observed in the liver
These immune-mediated events were compounded by intolerable gastrointestinal side effects, including nausea in 59% and vomiting in 37% of participants, along with reports of acute pancreatitis, culminating in a dropout rate of 2634% in Phase 3 trials [65]